A carregar...
Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
BACKGROUND AND IMPORTANCE: Recurrent malignant gliomas (RMGs) are very difficult to control, and no standard treatments have been established for them. We performed boron neutron capture therapy (BNCT) for patients with RMG. BNCT enables high-dose particle radiation to be applied selectively to tumo...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3923505/ https://ncbi.nlm.nih.gov/pubmed/24387301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-9-6 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|